Stockreport

iCAD Announces Study Demonstrating Economic and Health Benefits of Intraoperative Radiation Therapy (IORT) for Early-Stage Breast Cancer Treatment

icad inc.  (ICAD) 
Last icad inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: icadmed.com/financial-news-and-events.html
PDF Lifetime cost-effectiveness analysis reveals $630 million annual cost savings, less radiation exposure and better quality of life for patients compared to external beam [Read more]